WO2012074285A3 - 펩타이드 또는 단백질 안정화제 - Google Patents

펩타이드 또는 단백질 안정화제 Download PDF

Info

Publication number
WO2012074285A3
WO2012074285A3 PCT/KR2011/009190 KR2011009190W WO2012074285A3 WO 2012074285 A3 WO2012074285 A3 WO 2012074285A3 KR 2011009190 W KR2011009190 W KR 2011009190W WO 2012074285 A3 WO2012074285 A3 WO 2012074285A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
peptides
agent
stabilizing peptides
panthenol
Prior art date
Application number
PCT/KR2011/009190
Other languages
English (en)
French (fr)
Other versions
WO2012074285A2 (ko
Inventor
이창근
김혁
김정환
신홍주
박원석
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Publication of WO2012074285A2 publication Critical patent/WO2012074285A2/ko
Publication of WO2012074285A3 publication Critical patent/WO2012074285A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 판테놀, 폴리알코올 에스터계 화합물, 카제인 및 그들의 유도체로 이루어진 그룹에서 선택된 하나 이상을 포함하는 펩타이드 또는 단백질 안정화용 조성물을 개시한다. 또한 펩타이드 및 단백질 중 하나 이상; 및 판테놀, 폴리알코올 에스터계 화합물, 카제인 및 그들의 유도체로 이루어진 그룹에서 선택된 하나 이상을 포함하는 조성물을 개시한다. 본 발명은 펩타이드 및 단백질 중 하나 이상; 및 판테놀, 폴리알코올 에스터계 화합물, 카제인 및 그들의 유도체로 이루어진 그룹에서 선택된 하나 이상을 혼합하여 조성물을 제조하는 단계를 포함하는 펩타이드 또는 단백질 안정화 방법을 개시한다.
PCT/KR2011/009190 2010-11-30 2011-11-30 펩타이드 또는 단백질 안정화제 WO2012074285A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0120841 2010-11-30
KR20100120841 2010-11-30

Publications (2)

Publication Number Publication Date
WO2012074285A2 WO2012074285A2 (ko) 2012-06-07
WO2012074285A3 true WO2012074285A3 (ko) 2012-08-23

Family

ID=46172395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/009190 WO2012074285A2 (ko) 2010-11-30 2011-11-30 펩타이드 또는 단백질 안정화제

Country Status (2)

Country Link
KR (2) KR101949270B1 (ko)
WO (1) WO2012074285A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644532B (zh) * 2013-11-20 2019-08-09 株式会社爱茉莉太平洋 使用天然乳化剂的低粘度化妆品组合物
KR102328178B1 (ko) 2019-12-16 2021-11-18 주식회사 젠트리바이오 파에오놀 및 판테놀 또는 이들의 약학적으로 혀용가능한 염을 유효성분으로 포함하는 외용제 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316013A (ja) * 1993-12-30 1995-12-05 L'oreal Sa 皮膚の表面層と深層とに同時に作用する保湿性組成物及びその用途
JP2005516048A (ja) * 2002-01-30 2005-06-02 ザ プロクター アンド ギャンブル カンパニー 加水分解タンパク質を含有する局所用皮膚及び／又は毛髪組成物
US20070053852A1 (en) * 2003-05-28 2007-03-08 Beutler Rolf D Lipidic protein-transfer systems and cosmetic/dermatological use thereof
EP2248518A1 (en) * 2009-04-17 2010-11-10 Merz Pharma GmbH & Co. KGaA Formulation for stabilizing proteins, which is free of mammalian excipients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
US4944948A (en) 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
IL149778A0 (en) 1999-11-22 2002-11-10 Universal Preservation Technologies Inc Preservation of sensitive biological material
JP4176768B2 (ja) * 2002-11-28 2008-11-05 ケラテク リミテッド ケラチンを含むパーソナルケア配合物
BR0316862A (pt) * 2003-08-11 2005-10-25 Andres Franco Velasco Regenerador capilar
KR100619289B1 (ko) * 2004-01-29 2007-04-12 종근당건강 주식회사 초유와 알부틴을 이용한 미백 기능성 화장품 및 그 제조방법
KR100824396B1 (ko) * 2006-10-10 2008-04-22 (주)케어젠 상피세포 성장인자의 활성을 가지는 펩타이드 및 그의 용도
WO2008079898A1 (en) * 2006-12-20 2008-07-03 Pharmwest, Inc. Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions
KR101021197B1 (ko) * 2008-04-11 2011-03-11 (주)케어젠 성장인자―미미킹 펩타이드 및 그의 용도

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07316013A (ja) * 1993-12-30 1995-12-05 L'oreal Sa 皮膚の表面層と深層とに同時に作用する保湿性組成物及びその用途
JP2005516048A (ja) * 2002-01-30 2005-06-02 ザ プロクター アンド ギャンブル カンパニー 加水分解タンパク質を含有する局所用皮膚及び／又は毛髪組成物
US20070053852A1 (en) * 2003-05-28 2007-03-08 Beutler Rolf D Lipidic protein-transfer systems and cosmetic/dermatological use thereof
EP2248518A1 (en) * 2009-04-17 2010-11-10 Merz Pharma GmbH & Co. KGaA Formulation for stabilizing proteins, which is free of mammalian excipients

Also Published As

Publication number Publication date
KR101949270B1 (ko) 2019-02-19
KR101949272B1 (ko) 2019-02-19
WO2012074285A2 (ko) 2012-06-07
KR20170125780A (ko) 2017-11-15
KR20120059429A (ko) 2012-06-08

Similar Documents

Publication Publication Date Title
IL273607A (en) Humanized antibodies against liv-1, preparations containing them and their uses
WO2012016227A3 (en) Antibodies with modified isoelectric points
EP3284772B8 (en) Thioethers, methods for their preparation, and compositions including such thioethers
WO2012061290A3 (en) Pesticidal compositions and processes related thereto
WO2012033813A3 (en) Compositions for dyeing keratin fibers
WO2012116246A3 (en) Pesticidal compostions and processes related thereto
PL2547692T3 (pl) Pochodne peptydów, ich wytwarzanie i ich zastosowania
IL226383B (en) Antibodies against ccl20, preparations containing them and their uses
WO2012087288A3 (en) Metal salt compositions
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2012058211A3 (en) Quinazoline derivatives, compositions, and uses related thereto
IL225460A0 (en) Antibodies that bind to p4d12191, preparations containing them and their uses
WO2010129313A3 (en) Cosmetic compositions comprising cyanodiphenylacrylates
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
SG195194A1 (en) Nanogels
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
IL226270A0 (en) History of hydroxamic acid, preparations containing them and their uses
WO2010006173A3 (en) Mineral amino acid polysaccharide complex
WO2013000922A9 (en) Ccr2 antagonist peptides
ZA201301463B (en) Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
WO2011116256A3 (en) Multiphase microarrays and uses thereof
IL232867B (en) Amyloid-binding polypeptide and chimeric protein containing it, pharmaceutical preparations containing the polypeptide or chimeric protein, methods for their preparation and uses
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
WO2010136104A3 (en) Anti-dandruff agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11845768

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 13.09.2013.)

122 Ep: pct application non-entry in european phase

Ref document number: 11845768

Country of ref document: EP

Kind code of ref document: A2